Delaying Prostate-Specific Antigen Progression in Biochemically Recurrent Prostate Cancer: Is It Clinically Meaningful?

被引：0
|
作者：
Childs, Daniel S. [1 ]
Orme, Jacob J. [1 ]
Ravi, Praful [2 ]
机构：
[1] Mayo Clin, Dept Oncol, 200 First St SW, Rochester, MN 55905 USA
[2] Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 10期
关键词：
ABIRATERONE ACETATE; ENZALUTAMIDE; INTERMITTENT; SURVIVAL; RISK;
D O I：
10.1200/JCO.23.02410
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Prostate-specific antigen and prostate-specific antigen derivatives as predictors of benign prostatic hyperplasia progression
    Levitt J.M.
    Slawin K.M.
    Current Urology Reports, 2007, 8 (4) : 269 - 274
  • [22] CANCER (PROSTATE-SPECIFIC ANTIGEN)
    CASTELLANI, WJ
    ANALYTICAL CHEMISTRY, 1995, 67 (12) : R399 - R403
  • [23] Incorporating Prostate-specific Membrane Antigen Positron Emission Tomography in Management Decisions for Men with Newly Diagnosed or Biochemically Recurrent Prostate Cancer
    Bukavina, Laura
    Luckenbaugh, Amy N.
    Hofman, Michael S.
    Hope, Tom
    Kamran, Sophia C.
    Murphy, Declan G.
    Yamoah, Kosj
    Ost, Piet
    EUROPEAN UROLOGY, 2023, 83 (06) : 521 - 533
  • [24] PROSTATE-SPECIFIC ANTIGEN AND RADIATION-THERAPY FOR CLINICALLY LOCALIZED PROSTATE-CANCER
    ZAGARS, GK
    POLLACK, A
    KAVADI, VS
    VONESCHENBACH, AC
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 32 (02): : 293 - 306
  • [25] Racial differences in prostate-specific antigen levels and prostate-specific antigen densities in patients with prostate cancer
    Abdalla, I
    Ray, P
    Ray, V
    Vaida, F
    Vijayakumar, S
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (06): : 537 - 541
  • [26] Clinical use of prostate-specific antigen and prostate-specific antigen density in the staging of patients with cancer of the prostate
    Wolff, JM
    Boeckmann, W
    Effert, PJ
    Handt, S
    Jakse, G
    EUROPEAN UROLOGY, 1996, 30 (04) : 451 - 457
  • [27] The use of prostate-specific antigen and free/total prostate-specific antigen in the diagnosis of localized prostate cancer
    Partin, AW
    Carter, HB
    UROLOGIC CLINICS OF NORTH AMERICA, 1996, 23 (04) : 531 - +
  • [28] Value of prostate-specific antigen: Are higher levels meaningful?
    Dunn, FB
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (06) : 415 - 416
  • [29] Complexed prostate-specific antigen and the "prostate-specific antigen gap"
    Croal, BL
    Mitchell, I
    Dickie, A
    Duff, PA
    Cohen, NP
    Ross, IS
    CLINICAL CHEMISTRY, 1999, 45 (11) : 2040 - 2040
  • [30] Prostate-specific membrane antigen positron emission tomography in the management of recurrent prostate cancer
    Afaq, Asim
    Bomanji, Jamshed
    BRITISH MEDICAL BULLETIN, 2018, 128 (01) : 37 - 48
12345